Answer
No. It improves the function of responsive CFTR protein but does not remove the underlying inherited mutation.
Sources for this answer
- Alyftrek 50 mg/20 mg/4 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.